ARKG vs. GSKH

Last updated Jun 24, 2026

ARKG (ARK Genomic Revolution Multi-Sector ETF) and GSKH (GSK plc ADRhedged ETF) are both Health & Biotech Equities funds. ARKG is actively managed, while GSKH is passively managed. Over the past year, ARKG returned 52.71% vs 42.66% for GSKH. At a 0.16 correlation, their price movements are largely independent. ARKG charges 0.75%/yr vs 0.19%/yr for GSKH.

Performance

ARKG vs. GSKH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and GSK plc ADRhedged ETF (GSKH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARKG achieves a 24.30% return, which is significantly higher than GSKH's 9.90% return.

ARKG

• 1D: -1.07%
• 1M: 17.41%
• YTD: 24.30%
• 6M: 19.48%
• 1Y: 52.71%
• 3Y*: 3.17%
• 5Y*: -16.56%
• 10Y*: 8.67%

GSKH

• 1D: 2.87%
• 1M: 2.94%
• YTD: 9.90%
• 6M: 10.56%
• 1Y: 42.66%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. GSKH - Yearly Performance Comparison

	2026 (YTD)	2025
ARKG ARK Genomic Revolution Multi-Sector ETF	24.30%	10.74%
GSKH GSK plc ADRhedged ETF	9.90%	36.51%

Correlation

The correlation between ARKG and GSKH is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (All Time) Calculated using the full available price history since Jan 7, 2025	0.16

Return for Risk

ARKG vs. GSKH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG

ARKG Risk / Return Rank: 36
ARKG Sharpe Ratio Rank: 36
ARKG Sortino Ratio Rank: 38
ARKG Omega Ratio Rank: 34
ARKG Calmar Ratio Rank: 40
ARKG Martin Ratio Rank: 32

GSKH

GSKH Risk / Return Rank: 51
GSKH Sharpe Ratio Rank: 53
GSKH Sortino Ratio Rank: 56
GSKH Omega Ratio Rank: 54
GSKH Calmar Ratio Rank: 51
GSKH Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. GSKH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and GSK plc ADRhedged ETF (GSKH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ARKG	GSKH	Difference
Sharpe ratio: Return per unit of total volatility	1.25	1.64	-0.39
Sortino ratio: Return per unit of downside risk	1.91	2.43	-0.51
Omega ratio: Gain probability vs. loss probability	1.22	1.30	-0.09
Calmar ratio: Return relative to maximum drawdown	1.93	2.31	-0.39
Martin ratio: Return relative to average drawdown	4.58	6.06	-1.47

ARKG vs. GSKH - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.25, which is comparable to the GSKH Sharpe Ratio of 1.64. The chart below compares the historical Sharpe Ratios of ARKG and GSKH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ARKG vs. GSKH - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than GSKH's maximum drawdown of -18.54%. Use the drawdown chart below to compare losses from any high point for ARKG and GSKH.

Drawdown Indicators

	ARKG	GSKH	Difference
Max Drawdown Largest peak-to-trough decline	-83.59%	-18.54%	-65.05%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-18.54%	-8.97%
Max Drawdown (3Y) Largest decline over 3 years	-51.96%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-80.18%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-83.59%	—	—
Current Drawdown Current decline from peak	-67.78%	-11.62%	-56.16%
Average Drawdown Average peak-to-trough decline	-36.02%	-5.86%	-30.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.53%	7.06%	+4.47%

Volatility

ARKG vs. GSKH - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.19% compared to GSK plc ADRhedged ETF (GSKH) at 6.89%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than GSKH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARKG	GSKH	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.19%	6.89%	+8.30%
Volatility (6M) Calculated over the trailing 6-month period	30.91%	18.67%	+12.24%
Volatility (1Y) Calculated over the trailing 1-year period	42.54%	26.14%	+16.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.93%	26.95%	+18.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.29%	26.95%	+14.34%

ARKG vs. GSKH - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than GSKH's 0.19% expense ratio.

Dividends

ARKG vs. GSKH - Dividend Comparison

ARKG has not paid dividends to shareholders, while GSKH's dividend yield for the trailing twelve months is around 2.82%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%
GSKH GSK plc ADRhedged ETF	2.82%	1.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both ARKG and GSKH in my portfolio?

ARKG and GSKH have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARKG or GSKH?

ARKG has higher volatility (15.19%) compared to GSKH (6.89%). In terms of maximum drawdown, ARKG dropped -83.59% vs GSKH's -18.54%.

Which ETF is better, ARKG or GSKH?

On 1-year performance, ARKG leads with 52.71% vs 42.66% for GSKH. On fees, GSKH is cheaper at 0.19% per year. On volatility, GSKH has been the lower-risk option at 6.89%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, ARKG or GSKH?

Over the 1-year period, ARKG has performed better with a 52.71% return vs 42.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, ARKG or GSKH?

GSKH is cheaper with a 0.19% expense ratio, compared with 0.75% for ARKG.

Which ETF pays a higher dividend yield, ARKG or GSKH?

GSKH has the higher dividend yield at 2.82%, compared with 0.00% for ARKG.

What is the main difference between ARKG and GSKH?

They also come from different issuers: ARK and ADRhedged. Their fees differ too: 0.75% for ARKG and 0.19% for GSKH.

Which has better risk-adjusted returns?

GSKH currently has the higher Sharpe Ratio (1.64 vs 1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.